Literature DB >> 6983610

Intensive suppression of experimental allergic encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for multiple sclerosis.

Y Nagai, T Osanai, K Sakakibara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983610

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


× No keyword cloud information.
  6 in total

1.  Serum thymic factor as a radioprotective agent promoting survival after X-irradiation.

Authors:  H Kobayashi; H Abe; A Awaya; H Inano; M Shikita
Journal:  Experientia       Date:  1990-05-15

2.  Suppression of acute experimental allergic encephalomyelitis by synthetic serum thymic factor. Clinical, histopathological, and immunohistochemical studies.

Authors:  S Kato; H Nakamura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Anti-thyroglobulin antibodies induced with recombinant reovirus infection in BALB/c mice.

Authors:  T Onodera; A Awaya
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

4.  Reovirus type 2-induced diabetes in mice prevented by immunosuppression and thymic hormone.

Authors:  T Onodera; T Taniguchi; K Yoshihara; S Shimizu; M Sato; T Hayashi
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

5.  Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier.

Authors:  T Osanai; Y Nagai
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

Review 6.  Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application.

Authors:  Martina Severa; Jing Zhang; Elena Giacomini; Fabiana Rizzo; Marilena Paola Etna; Melania Cruciani; Enrico Garaci; Michael Chopp; Eliana Marina Coccia
Journal:  Mult Scler Relat Disord       Date:  2018-10-02       Impact factor: 4.339

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.